We’re proud to share that Shoulder Innovations, Inc., a cultivate(MD) portfolio company and leader in shoulder surgical technology, has announced the pricing of its initial public offering of 5,000,000 shares of common stock at $15.00 per share. Shoulder Innovations is now publicly listed on the New York Stock Exchange under the ticker symbol “SI.” This […]
Shoulder Innovations Stock Debuts on NYSE Under Ticker “SI” Read More »
GRAND RAPIDS, MI – June 24, 2025 – cultivate(MD), a leading medical device venture capital company, is pleased to announce that its portfolio company, Virtual Incision Corporation, the developer of the MIRA Surgical System authorized by the FDA through the De Novo regulatory pathway, has appointed Jim Alecxih as chief executive officer. Alecxih, a recognized commercial leader in the medical device industry,
We’re proud to share that HAPPE Spine, a portfolio company of cultivate(MD), has been selected for the MedTech Innovator 2025 Accelerator Cohort, an honor reserved for the top 4% of nearly 1,500 global applicants. This recognition reflects both the strength of HAPPE’s mission and the game-changing potential of their breakthrough spinal implant technology. MedTech Innovator
HAPPE Spine Selected for MedTech Innovator 2025 Accelerator Cohort Read More »
Grand Rapids, MI – June 11, 2025 – cultivate(MD), a leading medical device venture capital company, is pleased to announce the acquisition of its portfolio company, Sterile Processing Express (SPDx), by Instrumentum, LLC, a fast-growing leader in surgical instrument sterilization services. This strategic acquisition expands Instrumentum’s operational footprint to five facilities across four states, significantly enhancing its capacity
cultivate(MD) Announces Acquisition of Portfolio Company SPDx by Instrumentum Read More »
Nanochon, a cultivate(MD) portfolio company, has launched a new podcast titled “ChonChats,” hosted by Benjamin Holmes and Rachel Offenburg. The inaugural episode features R. Sean Churchill, MD, MBA, discussing:
Dr. Sean Churchill, MBA Joins Nanochon’s ChonChats Read More »
Virtual Incision, a cultivate(MD) portfolio company, has announced plans to explore the use of Nvidia Isaac for Healthcare to advance next-generation surgical robotics. The company intends to harness the digital twin framework and robotic learning tools provided by Nvidia. This integration could enable the creation of highly detailed virtual environments to simulate complex surgical procedures
Virtual Incision to Explore Nvidia AI for Surgical Robotics Read More »
Grand Rapids, MI – March 10, 2025 – Shoulder Innovations, a cultivate(MD) portfolio company, and a leader in shoulder replacement technology, today announced the closing of a $40 million Series E equity financing round. The financing was led by existing investor U.S. Venture Partners (USVP), with support from additional existing investors including Gilde Healthcare Partners, Gilmartin Capital,
Shoulder Innovations Announces Closing of $40 Million Series E Equity Financing Read More »
Strados Labs, a cultivate(MD) portfolio company announced a new collaboration with Beth Israel Deaconess Medical Center (BIDMC). The upcoming study will evaluate the use of Strados Labs’ RESP® Biosensor, an FDA-cleared wearable stethoscope technology, for the early detection of pulmonary edema in critically ill patients on mechanical ventilation (MV). This pilot study is scheduled to
We’re excited to announce that Dr. Ryan Roeder from HAPPE Spine will be delivering a scientific presentation on “Next Generation PEEK Interbody Fusion Devices: Scientific Foundations and Clinical Outcomes” Thursday, August 15, 2024 at 7 PM CT. This pre-meeting webinar is part of the upcoming North American Spine Society (NASS) conference, and it’s an incredible
Dr. Ryan Roeder Presenting at NASS Webinar Read More »
Grand Rapids, MI – August 12, 2024 – cultivate(MD), a leading medical device venture capital company announced today its participation in the successful Series A extension round of Prana Thoracic, a Houston-based medtech startup. The round, which was oversubscribed by 30%, secured an additional $3 million, bringing Prana Thoracic’s total funding to $9 million. This achievement underscores the
cultivate(MD) Invests in Prana Thoracic Read More »
